Tumors

DMG-PEG2000-K237 (DMG-PEG2000-Mal-Cys-HTMYYHHYQHHL) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a K237 peptide as a terminal targeting/functional ligand. DMG-PEG2000-K237 can be used in research on tumor-targeted drug delivery.

DMG-PEG2000-CGKRK (DMG-PEG2000-Mal-Cys-CGKRK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CGKRK peptide as a terminal targeting/functional ligand. DMG-PEG2000-CGKRK can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.

DSG-PEG2000-NGR (DSG-PEG2000-Mal-Cys-NGR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an NGR (HY-P1043) peptide as a terminal targeting/functional ligand. DSG-PEG2000-NGR can be used for tumor angiogenesis-targeted drug delivery.

DMG-PEG2000-GRGDS (DMG-PEG2000-Mal-Cys-GRGDS) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dispalmitoyl-sn-glycerol-3-phosphoethanolamine (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a Gly-Arg-Gly-Asp-Ser (GRGDS) (HY-P0295) peptide as a terminal targeting/functional ligand. DMG-PEG2000-GRGDS can be used in research on tumor-targeted drug delivery.

DMG-PEG2000-CREKA (DMG-PEG2000-Mal-Cys-CREKA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CREKA (HY-P10709) peptide as a terminal targeting/functional ligand. DMG-PEG2000-CREKA can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.

DSG-PEG2000-PTP (DSG-PEG2000-Mal-Cys-KTLLPTP) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a PTP (HY-P11850) peptide as a terminal targeting/functional ligand. DSG-PEG2000-PTP can be used in research on targeted drug delivery for pancreatic cancer.

DMG-PEG2000-VHPKQHRGGSKGC is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a VHPKQHRGGSKGC (HY-P11088A) peptide as a terminal targeting/functional ligand. DMG-PEG2000-VHPKQHRGGSKGC can be used in research on targeted drug delivery in inflammation, tumor angiogenesis, and atherosclerosis.

DSG-PEG2000-K237 (DSG-PEG2000-Mal-Cys-HTMYYHHYQHHL) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a K237 peptide as a terminal targeting/functional ligand. DSG-PEG2000-K237 can be used in research on tumor-targeted drug delivery.

DMG-PEG2000-CTT2 is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the CTT2 peptide as a terminal targeting/functional ligand. DMG-PEG2000-CTT2 can be used in research on targeted drug delivery to the tumor microenvironment.

DMG-PEG2000-LTLRWVGLMS (DMG-PEG2000-Mal-Cys-LTLRWVGLMS) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an LTLRWVGLMS peptide as a terminal targeting/functional ligand. DMG-PEG2000-LTLRWVGLMS can be used in research on targeted drug delivery for gliomas.

DSG-PEG2000-LTLRWVGLMS (DSG-PEG2000-Mal-Cys-LTLRWVGLMS) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an LTLRWVGLMS peptide as a terminal targeting/functional ligand. DSG-PEG2000-LTLRWVGLMS can be used in research on targeted drug delivery for gliomas.

DMG-PEG2000-SP94 (DMG-PEG2000-Mal-Cys-SP94) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an SP94 (HY-P11050A) peptide as a terminal targeting/functional ligand. DMG-PEG2000-SP94 can be used in research on targeted drug delivery for hepatocellular carcinoma.

DMG-PEG2000-DHLASLWWGTEL (DMG-PEG2000-Mal-Cys-DHLASLWWGTEL) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and the DHLASLWWGTEL peptide as a terminal targeting/functional ligand. DMG-PEG2000-DHLASLWWGTEL can be used in research on targeted drug delivery for hepatocellular carcinoma.

DMG-PEG2000-NYZL1 (DMG-PEG2000-Mal-Cys-NYZL1) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and the NYZL1 peptide as a terminal targeting/functional ligand. DMG-PEG2000-NYZL1 can be used in research on targeted drug delivery for bladder cancer, among other applications.

DSPE-PEG5000-VHPKQHRGGSKGC is a targeted modified phospholipid-polyethylene glycol conjugate covalently coupled to DSPE, PEG, and the vascular-targeting peptide VHPKQHRGGSKGC. DSPE-PEG5000-VHPKQHRGGSKGC can be used in research on tumor vascular imaging and vascular-targeted drug delivery.

DSPE-PEG5000-Glucose is a conjugate composed of DSPE, a PEG chain, and terminal glucose. DSPE-PEG5000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.

DSPE-PEG5000-DHLASLWWGTEL is a PEG compound which composed of DSPE and a GPC3 targeting peptide DHLASLWWGTEL. The DHLASLWWGTEL peptide partially and specifically binds to GPC3-positive cells, achieving precise targeting. DSPE-PEG5000-DHLASLWWGTEL can be used for drug delivery.

DSPE-PEG3400-VHPKQHRGGSKGC is a targeted modified phospholipid-polyethylene glycol conjugate covalently coupled to DSPE, PEG, and the vascular-targeting peptide VHPKQHRGGSKGC. DSPE-PEG3400-VHPKQHRGGSKGC can be used for research on tumor vascular imaging and vascular-targeted drug delivery.

DSPE-PEG3400-Glucose is a conjugate composed of DSPE, a PEG chain, and terminal glucose. DSPE-PEG3400-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.

DSPE-PEG3400-DHLASLWWGTEL is a PEG compound which composed of DSPE and a GPC3 targeting peptide DHLASLWWGTEL. The DHLASLWWGTEL peptide partially and specifically binds to GPC3-positive cells, achieving precise targeting. DSPE-PEG3400-DHLASLWWGTEL can be used for drug delivery.